Regulatory Q&A Forum

Ask questions, share knowledge, and get help from the regulatory community

As manufacturers plan their regulatory budgets for 2026 and beyond, a common question arises regarding the cost of outsourcing the Person Responsible for Regulatory Compliance (PRRC) role as required ...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 35 ๐Ÿ‘ 1
Asked: 2 months ago
Asked by Lo H. Khamis

When medical device manufacturers, particularly small or micro-enterprises, plan to outsource the Person Responsible for Regulatory Compliance (PRRC) role under the EU MDR, how can they develop a comp...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 24 ๐Ÿ‘ 0
Asked: 2 months ago
Asked by Lo H. Khamis

For non-EU manufacturers of AI-enabled technologies, such as certain Software as a Medical Device (SaMD), how are the requirements for an EU AI Act 'Authorised Representative' expected to intersect wi...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 38 ๐Ÿ‘ 0
Asked: 2 months ago
Asked by Lo H. Khamis

For non-EU companies developing AI systems that process personal data from individuals in the European Union, navigating the complex regulatory landscape is a significant challenge. With the enforceme...

๐Ÿ’ฌ 1 โœ“ ๐Ÿ‘๏ธ 35 ๐Ÿ‘ 0
Asked: 2 months ago
Asked by Lo H. Khamis

For non-EU medical device manufacturers, appointing an EU Authorized Representative (AR) is a mandatory step for placing products on the European market under the Medical Device Regulation (EU) 2017/7...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 43 ๐Ÿ‘ 2
Asked: 2 months ago
Asked by Lo H. Khamis

When selecting an EU Authorized Representative (AR) under the Medical Device Regulation (MDR), what key strategic and operational criteria should a non-EU manufacturer evaluate to ensure a compliant a...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 36 ๐Ÿ‘ 0
Asked: 2 months ago
Asked by Lo H. Khamis

Given the significant updates to cosmetic regulations in the United States, how should foreign cosmetic product manufacturers and processors approach the mandatory requirement to designate a U.S. Agen...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 23 ๐Ÿ‘ 2
Asked: 2 months ago
Asked by Lo H. Khamis

Given the recent FDA updates requiring foreign cosmetic facilities to register and appoint a United States agent, what key factors and service models should a company evaluate when selecting a U.S. Ag...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 51 ๐Ÿ‘ 0
Asked: 2 months ago
Asked by Lo H. Khamis

When a medical device manufacturer, particularly a small or micro-enterprise, decides to outsource the role of the Person Responsible for Regulatory Compliance (PRRC) under the EU Medical Device Regul...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 32 ๐Ÿ‘ 2
Asked: 2 months ago
Asked by Lo H. Khamis

For medical device startups targeting the European market, securing a Person Responsible for Regulatory Compliance (PRRC) is a mandatory step under the EU MDR. When outsourcing this role, how can a st...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 43 ๐Ÿ‘ 1
Asked: 2 months ago
Asked by Lo H. Khamis

For non-EU companies aiming to maintain or gain access to the European market, the REACH regulation requires the appointment of an Only Representative (OR) to manage registration and compliance obliga...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 19 ๐Ÿ‘ 2
Asked: 2 months ago
Asked by Lo H. Khamis

With significant updates to chemical regulations on the horizon, such as the proposed restrictions on per- and polyfluoroalkyl substances (PFAS) under REACH, how should non-EU medical device manufactu...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 21 ๐Ÿ‘ 2
Asked: 2 months ago
Asked by Lo H. Khamis

As non-EU providers of AI systems prepare for the implementation of the EU AI Act, a critical operational step is the appointment of an EU-based Authorized Representative (AR). A common question is ab...

๐Ÿ’ฌ 1 โœ“ ๐Ÿ‘๏ธ 7 ๐Ÿ‘ 2
Asked: 2 months ago
Asked by Lo H. Khamis

With the EU AI Act set to establish new compliance obligations for artificial intelligence systems placed on the European market, how should a non-EU provider of a high-risk AI system navigate the pro...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 25 ๐Ÿ‘ 0
Asked: 2 months ago
Asked by Lo H. Khamis

When medical device manufacturers evaluate potential EU Authorized Representatives (ARs) under the Medical Device Regulation (MDR), how can they move beyond comparing simple annual retainer fees to co...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 29 ๐Ÿ‘ 2
Asked: 2 months ago
Asked by Lo H. Khamis

With the implementation of the Modernization of Cosmetics Regulation Act (MoCRA), what are the specific requirements for designating an FDA U.S. Agent for foreign cosmetic facilities? Under MoCRA, an...

๐Ÿ’ฌ 1 โœ“ ๐Ÿ‘๏ธ 27 ๐Ÿ‘ 0
Asked: 2 months ago
Asked by Lo H. Khamis

With the implementation of the Modernization of Cosmetics Regulation Act (MoCRA), foreign cosmetic product facilities must now designate a United States agent. This agent serves as the FDA's primary p...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 30 ๐Ÿ‘ 1
Asked: 2 months ago
Asked by Lo H. Khamis

What factors determine the annual cost for an FDA U.S. Agent service? Foreign establishments marketing medical devices in the United States are required by regulation to designate a U.S. Agent, who s...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 9 ๐Ÿ‘ 2
Asked: 2 months ago
Asked by Lo H. Khamis

How should a medical device manufacturer evaluate a "PRRC as a Service" provider's capability to manage evolving European vigilance reporting requirements? As regulatory expectations for post-market s...

๐Ÿ’ฌ 1 ๐Ÿ‘๏ธ 28 ๐Ÿ‘ 2
Asked: 2 months ago
Asked by Lo H. Khamis

When budgeting for an outsourced Person Responsible for Regulatory Compliance (PRRC) under the EU MDR, manufacturers must look beyond a single price tag and instead analyze the key factors that determ...

๐Ÿ’ฌ 1 โœ“ ๐Ÿ‘๏ธ 23 ๐Ÿ‘ 2
Asked: 2 months ago
Asked by Lo H. Khamis
Showing page 22 of 54 (1079 total questions)